Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation p…
$7.21+4.80%
报价 2026-11-06
市值
$263.4M
EV
$209.2M
PE (TTM)
–
预期 PE
–
52 周区间距高点 -16.6%
$5.06$8.65
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Medical - Devices| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| PROFProfound Medical Corp. | $263.4M | +4.8% | – | 71.7% | – | – | – | |
| VMDViemed Healthcare, Inc. | $347.7M | +1.3% | +16.7% | 57% | 23.4x | 6.9x | 28.7x | GARP |
| OFIXOrthofix Medical Inc. | $318.1M | -11.8% | +4.9% | 69.6% | – | 5.7x | – | |
| CLPTClearPoint Neuro, Inc. | $275.7M | -1.0% | +45.1% | 62.6% | – | – | – | |
| TMCITreace Medical Concepts, Inc. | $262.1M | -3.6% | -2.7% | 79.5% | – | – | – | |
| LABStandard BioTools Inc. | $251M | +2.2% | +2.7% | 48.3% | – | – | – | |
| ELMDElectromed, Inc. | $225.2M | +1.5% | – | – | – | – | – | |
| TLSITriSalus Life Sciences, Inc. | $200.1M | -7.9% | +19.9% | 85.8% | – | – | – | |
| ANIKAnika Therapeutics, Inc. | $194.7M | -24.7% | +6.8% | 62.2% | – | 82.9x | 427.8x | |
| 同行中位数 | – | – | +6.8% | 62.6% | 23.4x | 6.9x | 228.3x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。
研究材料
Filing 摘要
电话会纪要摘要
暂无纪要摘要。